Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment

Fig. 1

Results of the meta-analysis on the change from baseline after one year. Fixed-effect meta-analysis, with treatment as moderator variable. Difference in changes from baseline between Placebo, AA and PXT3003 were assessed through contrast tests. a Change from baseline in CMTNS under Placebo, AA and PXT3003; b Change from baseline in ONLS under Placebo, AA and PXT3003. *p < 0.05; NS = not-significant

Back to article page